Remission in one-third of terminal lymphoma patients after gene therapy – BioNews
|
Remission in one-third of terminal lymphoma patients after gene therapy
BioNews The trial used genetically modified cells taken from the patient's own immune system, known as CAR-T therapy. After six months, cancer had shrunk by at least half in 82 percent of patients with non-Hodgkin lymphoma. 'The numbers are fantastic,' said Dr … |
